Lapho nje imiphumela yakho ilandela, i-Oryzon ingaba enye ye- izimanga ezinhle ngonyaka olandelayo ezimakethe zezimali zaseSpain. Ngoba isethula umkhawulo wokuthuthuka kuma-akhawunti ayo ebhizinisi ofanele ukubalulwa ngabahlaziyi bezezimali. Lapho inamandla okubuyekeza kabusha angaba namandla amakhulu uma okulindelwe okwenziwe emakethe yamasheya kuhlangatshezwana nakho, njengesici esiyinhloko kulesigaba sezokuphepha esibhalwe emakethe kazwelonke eqhubekayo.
Le nkampani esohlwini yasungulwa ngo-2000 eBarcelona, kanti i-Oryzon iyi- inkampani ye-biopharmaceutical isigaba somtholampilo umholi wase-Europe ku-Epigenetics. Lapho kugqame khona ngokuba nesinye sezikhundla ezinamandla kakhulu emkhakheni. Yize kuyisiphakamiso sokwenza ukonga kwethu kube nenzuzo, okuqhutshwa yimicabango enamandla, ngomqondo othile noma ngomunye. Lapho okufanayo ungathola inzuzo engama-20% ngesikhathi esifushane kakhulu kunokuyeka iphesenti elifanayo noma elingaphezulu kulesi sikhathi saphakade. Kugcinelwe abatshalizimali abancane nabaphakathi abakwaziyo ukusebenza nalezi zivikelo futhi abethula nokufunda okuthile ekuhambeni kwabo ezimakethe zezimali.
Ngenkathi ngakolunye uhlangothi, icwilisiwe emkhakheni, wezinkampani ze-biopharmaceutical, ebonakala ngokuguquguquka kwayo okuphezulu ekuvumelaneni kwamanani ayo. Ngokushesha lapho ingakhuphuka ngo-5% ukuthi ngosuku olulandelayo inani elifanayo lishiye kumaphesenti. Ziyizindinganiso ezihambisana kakhulu nokusebenza kwe- ukuhweba ngoba amamajini alo abanzi kakhulu kunoma yiluphi uhlobo lwecebo lokutshala imali. Ukuze ngale ndlela, wenze imali izuze ngendlela ebanzi kunangezinye izibambiso ezibalwe enkombeni ekhethiwe yamasheya aseSpain, i-Ibex 35.
U-Oryzon uhweba cishe ama-euro ama-2
Okwamanje, amasheya enkampani athengisa ngama-euro angaphezu kwamabili nje nangemva kokubuyekezwa konyaka okusunguliwe ngo-11%. Yize kunokwehluka okuningi enyangeni ngayinye njengoba kuyinkampani efakwe kuhlu eqhutshwa okulindelwe hhayi okwangempela. Njengomunye umehluko wayo omkhulu maqondana namanani okugcina okuqala ahlanganisiwe ku-Ibex 35. Lapho noma iliphi iphutha lingaholela ekwazisweni kwamaphesenti angama-5% noma amaphesenti aphezulu, njengoba kwenzekile eminyakeni yamuva nje.
Kunoma ikuphi, kuyinani lemakethe elinesisindo salo esibekiwe ngaphezulu kwama-euro angama-3 isabelo ngasinye. Ngamanye amagama, njengamanje inamandla okubonga acishe abe yi-15%. Ngokwalo mbono, akungabazeki ukuthi kuyisiphakamiso emalini kazwelonke esimema abantu ukuthi bathathe izikhundla ukwenza ukonga kube nenzuzo ngesikhathi esifushane. Yize kunezinhla nezikhathi eziningi bezihlupheka ezimakethe zezezimali.
Uhlobo lwenkampani
Le nkampani ingeyomkhakha omusha kakhulu futhi ayihlolisiswa kakhulu yimali yethu. Uma kungenjalo, kunalokho, kusengxenyeni evumayo ekwenzeni imisebenzi ye uhlamvu lokucabangela ukuthola imali yokuxazulula ukunyakaza emakethe yamasheya. Ngoba impela, futhi ukuze ube nemibono ecace kancane kusuka manje kuqhubeke, kulula kuwe ukwazi ukuthi yini umsebenzi wobuchwepheshe le nkampani efakwe kuhlu ebisenza. Ukuze ukwazi ukuthatha isinqumo esinolwazi oluningi futhi ngale ndlela ugweme ukuwela kuhlobo oluthile lwamaphutha olungalahlekisela izintshisekelo zakho. Futhi lokho kungenye yezinjongo zakho ezibalulekile manje.
Yebo, i-Oryzon Genomics, SA, inkampani yesigaba semitholampilo ye-biopharmaceutical igxile ku-epigenetics ekwakhiweni kwemithi ezifweni ezinezidingo ezibalulekile ezingaxazululeki. Ngamafuphi nje, umkhakha omusha kakhulu futhi owodwa wawo kunabamele abambalwa kakhulu ezimakethe zezimali zikazwelonke. Ngisho nasezimakethe zesibili ezifana ne- Enye iMakethe Yesitoko (MAB) abonakala ngokukhishwa kwemali ephezulu. Lapho ungaba nezinkinga ezithile ukulungisa amanani entengo wokungena nokuphuma kunani.
Izici zenani
Inkampani efakwe kuhlu, njengakulesi simo, ivelele ngaphezu kwakho konke ngoba ivolumu yayo yenkontileka incane kakhulu, njengoba hambisa nsuku zonke izihloko ezimbalwa kakhulu nokuthi ngandlela thile ingakulimaza ekunyakazeni ozokwenza kusukela manje. Phakathi kwezinye izizathu ngoba awukwazi ukuthenga ngaso sonke isikhathi ngesikhathi osifunayo. Njengesinye sezibonakaliso zobunikazi kulesi sigaba seziphakamiso ezisanda kuvela ezingezona izihloko ezifunwa kakhulu ukudala ukushintshana okulondoloziwe okuzinzile kwesikhathi esimaphakathi nesikhathi eside. Futhi kwezinye izimo, hhayi nangesikhathi esifushane ngenxa yezingozi ongazithatha kulolu hlobo lokuhweba emakethe yamasheya.
Ngenkathi ngakolunye uhlangothi, ungakhohlwa ukuthi leli nani elithile livame kakhulu ukwenza imisebenzi ezinsukwini ezimbalwa kakhulu, noma kungakapheli isikhathi esifanayo sokuhweba. Ukuthola inzuzo enkulu, ngokushesha kuba ngcono ngamasu akho okutshala imali. Impela hhayi ukubamba izikhundla izinyanga eziningi noma neminyaka. Ngenxa yalokhu unamanye amanani anconywa kakhulu kunoma imuphi umbono wokutshala imali. Isibonelo, labo abamele ngamalungu enkomba ekhethiwe yama-equities kazwelonke, i-Ibex 35. Ngezinketho ezifana neMapfre, Endesa, BBVA noma i-ACS.
Izingozi ekusebenzeni
Njengoba sishilo phambilini, enye yezingozi lapho uthatha izikhundla kulokhu kuphepha okukhethekile ingozi ebandakanyeka kulolu hlobo lokusebenza. Ngomqondo wokuthi noma ungahlala uthambekile noma ngokuphambene nokuthi ulahlekelwa ngokuqondile ama-euro amaningi endleleni. Ngoba ukhiye owodwa wokuhlala kunani ukwazi ukuthi ungaphuma kanjani ngesikhathi esifanele futhi ngaphandle kokunweba izikhundla ngaphansi kwanoma iziphi izimo. Ngempela, kufanele wazi kakhulu ngokuvela kwayo ezimakethe zezimali ngaphambi kokungenzeka kulezi zikhathi ezilandelayo zokuhweba.
Ngakolunye uhlangothi, kufanele futhi kugcizelelwe ukuthi leli nani akuvamile ukuba yingxenye yezikhundla zokutshalwa kwezimali ezilungiselelwe abaphathi, kuzwelonke nangaphandle kwemingcele yethu. Ngokungavikeleki ngandlela thile ezincomweni zabalamuli abahlukahlukene bezezimali. Lokho wukuthi, uzoba nezinkinga eziningi zokuthuthukisa noma yiliphi isu lokutshala imali futhi lokho kungakudalela okunye ukuphazamiseka ekusebenzeni. Ngokwendlela onqume ngayo ukwenza inzuzo inhlokodolobha emiselwe lokhu kuhamba emakethe yamasheya.
Ngokusebenza okuhlinzeka ukuphepha okuncane, njengoba kwenzeka ngokuphepha okuyingxenye ye-Ibex 35. Ngokwalokhu kubuka, kufanele wenze ngokuqapha okukhulu kakhulu kunalokhu ukuze ungabi nezimanga ezingezinhle ezingakwenza wehlise ibhalansi ye-akhawunti yakho yokonga. Kusuka kuphela kumamaki acatshangelwe kakhudlwana ngezintshisekelo zakho ezimakethe zezimali. Ngoba ekugcineni kosuku okumayelana nokwenza imali ibe nenzuzo ngokungatholakali kwezinye izindlela emholweni ohleliwe. Lapho inzalo ingadluli ku-0,3%, njengakumadiphozithi ebhange lesikhathi esinqunyiwe. Ngakho-ke, inkuthalo enkulu lapho kuvulwa izikhundla ngoba ubungozi buhlala bucashile nganoma yisiphi isikhathi. Ngaphezu kwalokho ongakholelwa kusukela ekuqaleni futhi lokho ngeke kukuholele ekuhlangabezaneni nezinhloso.
Khulisa umholo wakho ngama-42%
Imali engenayo ekupheleni kwekota yesithathu ka-2019 yale nkampani ifike kuma-euro ayizigidi eziyi-7,4, okungamaphesenti angama-42,3% ngaphezu kwekota yesithathu yonyaka ka-2018. kwezigidi ezingama-7,4 zama-euro. Kuhlelo utshalomali ku-R & D kungama-euro ayizigidi eziyi-8,2, okuyi-7,4 million euros ahambelana nentuthuko kanye no-0,8 million euros ocwaningweni oluthathwe ngqo ezindlekweni zalesi sikhathi, ezimele ukukhuphuka kwama-51,9% emandleni okutshala imali uma kuqhathaniswa nekota yesithathu ka-2018. unqume ukwenza imali eyinhloko ebekelwe lokhu kuhamba emakethe yamasheya kube nenzuzo.
Umphumela wensalela yebhalansi yayo yokubalwa kwemali ulahlekelwe ngama-euro ayizigidi ezingama-2,7, okuhambisana nokucaciswa kwemodeli yebhizinisi le-biotechnology, esigabeni sokuthuthuka lapho inkampani ikhona, ngesikhathi sokuvuthwa kwemikhiqizo yayo yesikhathi eside, futhi ngaphandle kokuphindeka kusuka kumbono weholo. Lapho ekupheleni kwekota yesithathu, imali etholakalayo kanye nokutshalwa kwezimali okutholakalayo kufinyelela kuma-euro ayizigidi ezingama-39,1. Ngenkathi ngakolunye uhlangothi, yenze ukwanda kwemali okulingana nama-euro ayizigidi ezingama-20,0, okuthola intshisekelo yabatshalizimali bamazwe aphesheya.